 |
|
GLYCOSIDES DEFINED
Source:
Wikipedia Encyclopedia
In
chemistry, glycosides are certain molecules in
which a sugar part is bound to some other part. Glycosides play
numerous important roles in living organisms. Many plants (and fruits)
store important chemicals in the form of inactive glycosides; if
these chemicals are needed, the glycosides are brought in contact
with water and an enzyme, and the sugar part is broken off, making
the chemical available for use. Many such plant glycosides are used
as medications. Formally, a glycoside is any molecule in which a
sugar group is bonded through its anomeric carbon to another group
via an O-glycosidic bond or an S-glycosidic bond; glycosides involving
the latter are also called thioglycosides. The given definition
is the one used by IUPAC. Many authors require in addition
that the sugar be bonded to a non-sugar for the molecule to qualify
as a glycoside, thus excluding the polysaccharides. The
sugar group is then known as the glycone and the non-sugar group
as the aglycone or genin part of the glycoside. The glycone can
consist of a single sugar group (monosaccharide) or several
sugar groups (oligosaccharide).
GLYCOSIDE HATCHLINGS
 |
Trutina
Dulcem’s ongoing glycoside research (since 1997)
has led to the development of TD “hatchlings”,
so called because they were borne/hatched from the original
kiwi fruit-extraction process.
These
new hatchlings are being developed from many
different species of fruit, while researchers keep intact
the phytochemical and glycoside benefits related to
each fruit.
|
|
SCIENTIFIC
DATA
CLINICAL TRIALS
|
Since 1997, Trutina Dulcem has undergone numerous Board Approved
Human In Vivo Clinical Trials in adults, children, and diabetics:
| • |
Trutina
Dulcem is Certified Low Glycemic, and has been clinically
proven not to stimulate human LPL Adipose Tissue Fat-Storage. |
| |
|
| • |
Trutina
Dulcem does not activate primary Lipoprotein Lipase human fat-storing
mechanisms, and does not elevate blood glucose or insulin
levels in normal persons and in type 2 diabetics. |
| |
|
| • |
Trutina
Dulcem has been shown to act as an “Anti-Carbohydrate”
in clinical trials |
DIABETIC
APPLICATIONS
Trutina Dulcem is an insulin-independent low glycemic carbohydrate.
Trutina Dulcem may be used in diabetic formulations including meal
replacement drinks and bars, medical feeding formulas, low glycemic
ice cream and candies, diabetic candies, and products for diabetic
children. Trutina Dulcem may serve a useful role in the dietary
management of blood sugar levels, since substitution of Trutina
Dulcem for other simple carbohydrates should lead to reduced post-prandial
glucose levels that will aid in overall control (click Diabetic
navigation button for Diabetic Chart).
In persons with type 2 diabetes, the requirement for insulin is
greater than that produced by the pancreas. Foods and sweeteners
that produce a lower secretion of insulin, ie, those that are low
glycemic, are known to be beneficial for glucose metabolism. In
type 2 diabetics, consuming 60 grams of Trutina Dulcem as compared
to their typical diabetic meal (for 12 weeks) resulted in decreases
in both serum glucose (SG) and glycated hemoglobin concentrations
(GHC), which progressively decreased in the group treated with Trutina
Dulcem. In the control group not using TD, both SG and GHC increased.
This resulted in improvements in glycemic control and alterations
in apoprotein composition, which decrease risk of coronary events
in humans. Utilizing low glycemic sweeteners and carbohydrates that
do not stimulate blood glucose and insulin levels is essential in
the long-term prevention of obesity in humans. The use of low glycemic
sweeteners that possess thermogenic properties further improves
short and long-term treatment of obesity and type 2 diabetes. Reducing
the use of high glycemic carbohydrates, sugars, and sweeteners while
increasing DIT improves incidence, risk, and development of said
disorders.
 |
TRUTINA
DULCEM ®
LICENSE
OF USE
|
|
Trutina Dulcem (TD) is only made
available to the medical, scientific, research, genetic, Pharmaceutical,
Functional Foods, and Nutraceutical industries.
TD
is not made available to the public at large, or for personal
or individual use.
Use
of Trutina Duclem requires a License-of-Use from the Trutina
Dulcem Division of Nutrilab Corporation. Exclusive licenses
for specific uses are reviewed.
Applications
to use Trutina Dulcem (in the appropriate areas as listed
above) may be made by requesting the PDF Application Form
(www.TrutinaDulcem.com).
|
|
 |
TRUTINA
DULCEM MANUFACTURING APPLICATIONS
Trutina Dulcem glycosides were developed for use in LOW GLYCEMIC
foods, beverages, and Nutraceuticals.
In Pharmaceutical applications, Trutina Dulcem can be utilized
in drug delivery, chemotherapy, tissue engineering, genetics,
Nanoparticle biotechnology, LOW GLYCEMIC cough syrups and preparations,
Sickle Cell, Dysregulated Arginine Metabolism, and amino acid
transport systems that cross the Blood-Brain-Barrier (BBB).
Trutina
Dulcem is the first (1997) proven LOW GLYCEMIC technology for
natural glycoside engineering. The evolution of utilizable sweet
glycosides occurs as a result of the (non-published, proprietary)
Trutina Dulcem 32-step process, including the removal of glycosides
from organic kiwi fruit.
|
NUTRIGENOMICS
Trutina Dulcem is currently utilized in the genetic research field
of NutriGenomics (www.GeneFoundation.com)
as a carrier-mediated-transporter in Sickle Cell disease, Alzheimer’s
disease, Thalassemia, Genetic Polymorphisms, Dysregulated Arginine
Metabolism, and generation of Pituitary Growth Hormone (GH).
|
These
statements have not been evaluated by the Food & Drug Administration.
The products promoted herein are not intended to diagnose, treat,
cure, or prevent any disease. |
Copyright © 2000-2010 Nutrilab Corporation
All rights reserved
No copies of this material, in part or in its entirety,
may be made and/or distributed.
|
|
